Filing Details

Accession Number:
0001127602-23-027077
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-09 09:04:17
Reporting Period:
2023-11-08
Accepted Time:
2023-11-09 09:04:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
310158 Merck & Co. Inc. MRK Pharmaceutical Preparations (2834) 221918501
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1421339 R. Richard Deluca Merck &Amp; Co., Inc.
126 East Lincoln Avenue
Rahway NJ 07065
Evp&Pres, Merck Animal Heallth No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-11-08 43,823 $105.03 111,764 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock - 401(K) Plan 1,223 Indirect By 401(k)
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.0000 to $105.0750, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
  2. Holdings include shares acquired in dividend reinvestment transactions.
  3. Includes shares acquired and dividends earned through October 6, 2023 in the Merck U.S. Savings Plan, a 401(k) plan.